Divi's Laboratories share news and announcements
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.
52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
- Next results date: the board meets on 7 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,37,594 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 1 Aug 2026
- 81.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 14.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 1 Aug 2026
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 1 Aug 2026
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,20,26160.6% delivered
Divi's Laboratories share news and announcements
636 announcements, routine notices left out, newest first. Page 13 of 13.
Jul 2007
30 Jul · Business
Press release titled "Divi's Labs PAT for Q1 grows by 153% to Rs.65 crores". which is has follows "Divi's Laboratories has earned a PAT of Rs.65 crores on a consolidated basis for the quarter ending 30th June, 2007. The total income grew by 39% to Rs.230 crores. An amount of Rs.2 crores has been charged as expense during the year on account of Stock options. For the first quarter of last year, it earned a PAT of Rs.26 crores on a total income of Rs.165 crores during the last year".30 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 22672 lacs for quarter ending on 30-JUN-2007 against Rs. 16069.12 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 6490 lacs for the quarter ending on 30-JUN-2007 against Rs. 2563.41 lacs for the quarter ending on 30-JUN-2006.30 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 22807 lacs for quarter ending on 30-JUN-2007 against Rs. 16083.9 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 6728 lacs for the quarter ending on 30-JUN-2007 against Rs. 2674.5 lacs for the quarter ending on 30-JUN-2006.20 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”10 Jul · Meeting
Share transfer books of the company will be closed from August 10, 2007 to August 13, 2007 (both days inclusive) for: i) Sub-division of Equity Shares of the Company to Rs.2/- per share from the existing Face Value of Rs.10/- per share and ii) Annual General Meeting of the Company scheduled to be held on September 03, 2007.10 Jul · Results
Report issued by Mr.V.Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal Ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) Rules 2001, in respect of (i) sub division of the equity shares of Rs.10/- each of the Company into 5 (Five) shares of Rs.2/- each and (ii) reappointment and enhancement of remuneration payable to Dr P Gundu Rao, Director (R&D) of the Company. Basing on the report submitted by the Scrutinizer, Mr. N V Ramana, Executive Director has declared on July 09, 2007 that the resolutions are passed with requisite majority. The company has further informed the Exchange that the members of the company have approved the (i) sub division of the Equity shares of the Company to Rs.2/- per share from the existing Face Value of Rs.10/- per share and (ii) reappointment and enhancement of remuneration payable to Dr P Gundu Rao, Director (R&D) of the Company. The details of the results of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Jul · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a dependent family member of a Director has intimated the Company on 27th June 2007, stating that she has sold the equity shares held by her in the company: (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 500; Date of Execution - 22.06.2007; Balance holding - 1052 Jul · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a Director have intimated the company on 27th June 2007, stating that he has sold the equity shares held by him in the company: (1) Name of the Director - Dr P Gundu Rao; No. of Shares sold - 500; Date of Execution - 22.06.2007; Balance holding - 257
Jun 2007
22 Jun · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a dependent family member of a Director has intimated the Company on 18th June 2007, stating that she has sold the equity shares held by her in the company : (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 95; Date of Execution - 14.06.2007; Balance holding - 60522 Jun · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insiders, who are Directors have intimated the company on 18th June 2007, stating that they have sold the equity shares held by them in the company : (1) Name of the Director - Dr P Gundu Rao; No. of Shares sold - 91; Date of Execution - 14.06.2007; Balance holding - 757. (2) Name of the Director - G V Rao; No. of Shares sold - 200; Date of Execution - 13.06.2007; Balance holding - 2008 Jun · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is dependent family member of a Director has intimated on 1st June 2007, stating that she has sold the equity shares held by her in the company : (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 300; Date of Execution - 31.05.2007; Balance holding - 7006 Jun · Meeting
Pursuant to Section 192A (2) of the Companies Act, 1956, read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, the company is seeking approval of the shareholders to pass the resolutions as Special Resolutions by way of Postal Ballot. The Company has appointed Mr. V. Bhaskara Rao, Practising Company Secretary as Scrutinizer for conducting the Postal Ballot process in a fair and transparent manner. The duly completed postal ballot form should reach the Scrutinizer not later than the close of working hours on July 06, 2007. The results of postal ballot will be announced by a Director of the Company on July 09, 2007. A copy of the Notice of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
23 May · Business
Press release titled "Divi's Labs PAT for FY07 grows by 167% to Rs.186 crores". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 May · Split of equity shares
Board of Directors of the Company, at their meeting held on May 23, 2007, have recommended split of Equity Shares from face value of Rs 10/- each to RS 2/- each, subject to approval of members. The Board decided to take the shareholders approval through postal Ballot and approved the notice along with explanatory statement to be sent to shareholders.21 May · Results
Report issued by Mr.V.Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal Ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) Rules 2001, in respect of four Ordinary Resolutions to increase the remuneration payable to Whole-time Directors of the company in accordance with the provisions of Sections 198, 269, 309, 310, 314 and other applicable provisions, if any read along with Schedule XIII of the Companies Act, 1956. Basing on the report submitted by the Scrutinizer, Dr P Gundu Rao, Director (R & D) has declared on May 19, 2007 that the resolutions are passed with requisite majority. The company has further informed the Exchange that the members of the company have approved increase of remuneration payable to whole-time Directors of the company, in accordance with the provisions of Sections 198, 269, 309, 310, 314 and other applicable provisions, if any read along with schedule XIII of the Companies Act, 1956. The details of the results of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 May · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director (R&D) of the company has intimated on 14th May 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of the Director - Dr P Gundu Rao; No. of Shares Gifted - 1000; Date of Execution - 14.05.2007; Balance holding - 84815 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2007.8 May · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee has intimated the company on 7th May 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of Designated Employee - S Chandra Divi; No. of Shares Gifted - 1556; Date of Execution - 05.05.2007; Balance holding - 13485 May · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee has intimated the company on 26th April 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of Designated Employee - S Devendra Rao; No. of Shares Sold - 276; Date of Execution - 25.04.2007; Balance holding - 21644 May · Disclosure
The 'purchase' by the Designated employees in the Annual Disclosure Statement submitted by the Company includes allotment of shares under ESOP Scheme besides the other purchases3 May · Disclosure
Annual disclosure statement of Directors of the Company for the year ended March 31, 2007 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
30 Apr · Disclosure
Two annual disclosure statements of employees and Directors of the Company for the year ended March 31, 2007 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Apr · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee, has intimated the company on 26th April 2007, stating that he has gifted to his relative the following equity shares held by him in the Company: (1) Name of Designated Employee:- Mr. S Devendra Rao; No. of Shares Sold:- 276; Date of Execution:- 25.04.2007; Balance holding:- 216424 Apr · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee, has intimated the company on 20th April 2007, stating that he has sold the equity shares held by him in the Company: (1) Name of Designated Employee:- Mr. B Vara Prasad; No. of Shares Sold:- 670; Date of Execution:- 17.04.2007; Balance holding:- 217 Apr · Results
The Audited Financial Results of the Company for the entire financial year 2006-2007 shall be considered and published by the Company within a period of three months from the end of the financial year, i.e. on or before 30th June 2007. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on 31st March 2007
Mar 2007
30 Mar · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations 2002, the insiders (as per list enclosed), who are designated employees, have intimated the Company, stating that their holdings have changed consequent to the allotment of shares under Employee Stock Option Scheme 2006 of the company. The details of the the list shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Mar · Outcome of meeting
Compensation Committee of Board of Directors in its meeting held on 17th March 2007 made the allotment of 92720 equity shares of Rs.10/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 12911420 equity shares from 12818700 equity shares19 Mar · Board meeting
Board of Directors in its meeting held on 17th March 2007 declared an interim dividend @ 100% (Rs.10/- per share) on Equity Capital of the Company for the financial year 2006-07 to all the Equity shareholders whose names appear in the Register of Members of the Company on 26th March 2007 being the record date fixed for the purpose of payment of aforesaid dividend12 Mar · Meeting Re-scheduled
Divi'S Laboratories Limited had informed the Exchange regarding Compensation Committee meeting scheduled to be held on March 15, 2007. The company has now informed the Exchange that the meeting of the Compensation Committee of the Company has been postponed to March 17, 2007, to allot the equity shares to employees in pursuance of the ESOP 2006.12 Mar · Board meeting
Inter-alia to consider and declare interim dividend on Equity Shares of the Company for the year ended 31st March, 2007 and if declared in the said Board meeting, 26th March, 2007 has been fixed as the record date for the purpose of payment of aforesaid dividend.7 Mar · Notice of Meeting
Meeting of the Compensation Committee is scheduled to be held on 15th March 2007 to allot the equity shares to employees in pursuance of the ESOP 2006.5 Mar · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is designated employee, has intimated the company on 1st March 2007, stating that he has acquired the equity shares of the Company : (1) Name of Designated Employee :- Mr. P Srinivas Rao; No. of Shares acquired :- 4500; Mode of Acquisition :- Market; Market Price :- Rs.2990; Total holding - 18991
Feb 2007
6 Feb · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulation, 2002, the following insider, who is designated employee, have intimated the company on 3rd February 2007, stating that they he have acquired on 31st January 2007 the shares of the Company : (1) Name of Designated Employee :- Mr. S. Rama Krishna; No. of Shares acquired :- 1000; Mode of Acquisition :- Market; Market Price :- Rs. 3170; Total holding - 5501
Jan 2007
27 Jan · Business
Press release, titled "Divi's Labs Q3 total income grows by 38% to Rs.152 crores". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Board meeting
Meeting on 27 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”4 Jan · Disclosure
The Oppenheimer Funds Inc. A/C Oppenheimer Developing Markets Fund, which holds more than 5% shares in the company, has sold 152312 No. of shares amounting to 1.19% of total shareholding, which has resulted in shareholding falling below 5%. As per Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and in terms of regulations 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992, company has to disclose purchase or sale aggregating 2% or more of total share capital of the company even if such change results in shareholding falling below 5%. In this case, though the change does not exceed 2% of total shareholding, we are intimating the same for your information and records. Name of Shareholder - Oppenheimer Funds Inc. A/C Oppenheimer Developing Markets Fund; No & % of shares Sold - 152312 (1.19%); Shareholding before Sale % - 641907 (5.01%); Shareholding after Sale % - 489595 (3.82%)